Assays for Assessing Mycobacterium avium Immunity and Evaluating the Effects of TherapeuticsPATHOGENSIF3.32024-10-150OAAI
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In VivoJOURNAL OF INFECTIOUS DISEASESIF4.52023-11-292PRE
Homodimeric Granzyme A Opsonizes Mycobacterium tuberculosis and Inhibits Its Intracellular Growth in Human Monocytes via Toll-Like Receptor 4 and CD14JOURNAL OF INFECTIOUS DISEASESIF4.52023-09-063PRE
Identification of immunodominant T cell epitopes induced by natural Zika virus infectionFRONTIERS IN IMMUNOLOGYIF5.92023-08-295OAAI
The role of Monocyte Chemoattractant Protein-Induced Protein-1 in the regulation of the immune responses to mycobacterial infectionJOURNAL OF IMMUNOLOGYIF3.42023-05-010OA
Mycobacterium tuberculosis induces immune evasion in macrophages through RNA-binding protein tristetraprolinJOURNAL OF IMMUNOLOGYIF3.42023-05-010OA
Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas diseaseFRONTIERS IN MICROBIOLOGYIF4.52022-11-291OAAI
Mechanistic Investigation of Granzyme A inhibitory effects on intracellular Mycobacterium tuberculosisJOURNAL OF IMMUNOLOGYIF3.42022-05-010PRE
Granzyme A Produced by γ9δ2 T Cells Activates ER Stress Responses and ATP Production, and Protects Against Intracellular Mycobacterial Replication Independent of Enzymatic ActivityFRONTIERS IN IMMUNOLOGYIF5.92021-08-0311OAAI
A Subset of Mycobacteria-Specific CD4+ IFN-γ+ T Cell Expressing Naive Phenotype Confers Protection against Tuberculosis Infection in the LungJOURNAL OF IMMUNOLOGYIF3.42019-08-157OAAI
BCG Vaccination Induces M. avium and M. abscessus Cross-Protective ImmunityFRONTIERS IN IMMUNOLOGYIF5.92019-02-1945OAAI
Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruziPLOS PATHOGENSIF4.92016-10-0373OAAI
Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective ImmunityPLOS PATHOGENSIF4.92016-09-199OAAI
Synthesis, antimalarial properties and 2D-QSAR studies of novel triazole-quinine conjugatesBIOORGANIC & MEDICINAL CHEMISTRYIF32016-08-0149PREAI
New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T CellsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52016-03-0118OAAI
Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agentsBIOORGANIC & MEDICINAL CHEMISTRYIF32015-08-0123OAAI
Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin MetabolitesJOURNAL OF IMMUNOLOGYIF3.42015-07-15111OAAI
An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8+ T cell epitopesHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52015-06-2414OAAI
Deficiency of Antigen-Specific B Cells Results in Decreased Trypanosoma cruzi Systemic but Not Mucosal Immunity Due to CD8 T Cell ExhaustionJOURNAL OF IMMUNOLOGYIF3.42015-02-1533OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向